Göm menyn

Publications for Nil Dizdar-Segrell


Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 37 times*

Journal Articles

Maria Nord, Anita Kullman, Ulf Hannestad and Nil Dizdar
  Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
  Advances in Parkinsons Disease, 2017, 06(01), .
   Fulltext  PDF  

Charalampos Georgiopoulos, Marcel Jan Bertus Warntjes, Nil Dizdar-Segrell, Helene Zachrisson, Maria Engström, Sven Haller and Elna-Marie Larsson
  Olfactory Impairment in Parkinsons Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging
  Journal of Parkinson's Disease, 2017, 7(2), 301-311.
   Fulltext  PDF  

Maria Nord, Peter Zsigmond, Anita Kullman and Nil Dizdar-Segrell
  Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease
  Advances in Parkinsons Disease, 2017, 6(2), 52-66.
   Fulltext  PDF  

Sven E. Pålhagen, Olof Sydow, Anders Johansson, Dag Nyholm, Bjorn Holmberg, Hakan Widner, Nil Dizdar Segrell, Jan Linder, Tove Hauge, Rasmus Jansson, Lars Bergmann, Susanna Kjellander and Thomas S. Marshall
  Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinsons disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
  Parkinsonism & Related Disorders, 2016, 29, 17-23.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Christina M. Lill, Aina Rengmark, Lasse Pihlstrom, Isabella Fogh, Aleksey Shatunov, Patrick M. Sleiman, Li-San Wang, Tian Liu, Christina F. Lassen, Esther Meissner, Panos Alexopoulos, Andrea Calvo, Adriano Chio, Nil Dizdar, Frank Faltraco, Lars Forsgren, Julia Kirchheiner, Alexander Kurz, Jan P. Larsen, Maria Liebsch, Jan Linder, Karen E. Morrison, Hans Nissbrandt, Markus Otto, Jens Pahnke, Amanda Partch, Gabriella Restagno, Dan Rujescu, Cathrin Schnack, Christopher E. Shaw, Pamela J. Shaw, Hayrettin Tumani, Ole-Bjorn Tysnes, Otto Valladares, Vincenzo Silani, Leonard H. van den Berg, Wouter van Rheenen, Jan H. Veldink, Ulman Lindenberger, Elisabeth Steinhagen-Thiessen, Stefan Teipel, Robert Perneczky, Hakon Hakonarson, Harald Hampel, Christine A. F. von Arnim, Jorgen H. Olsen, Vivianna M. Van Deerlin, Ammar Al-Chalabi, Mathias Toft, Beate Ritz and Lars Bertram
  The role of TREM2 R47H as a risk factor for Alzheimers disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinsons disease
  Alzheimer's & Dementia, 2015, 11(12), 1407-1416.
 Web of Science® Times Cited: 26

Lasse Pihlstrom, Aina Rengmark, Kari Anne Bjornara, Nil Dizdar, Camilla Fardell, Lars Forsgren, Bjorn Holmberg, Jan Petter Larsen, Jan Linder, Hans Nissbrandt, Ole-Bjorn Tysnes, Espen Dietrichs and Mathias Toft
  Fine mapping and resequencing of the PARK16 locus in Parkinsons disease
  Journal of Human Genetics, 2015, 60(7), 357-362.
 Web of Science® Times Cited: 9

Charalampos Georgiopoulos, Anette Davidsson, Maria Engström, Elna-Marie Larsson, Helene Zachrisson and Nil Dizdar
  The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes
  Journal of Neurology, 2015, 262(9), 2154-2163.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Anette Davidsson, Charalampos Georgiopoulos, Nil Dizdar, Göran Granerus and Helene Zachrisson
  Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinsons disease and Atypical Parkinsonian syndromes using DaTSCAN (R) SPECT
  Annals of Nuclear Medicine, 2014, 28(9), 851-859.
 Web of Science® Times Cited: 7

Peter Zsigmond, Maria Nord, Anita Kullman, Elin Diczfalusy, Karin Wårdell and Nil Dizdar
  Neurotransmitter levels in basal ganglia during levodopa and deep brain stimulation treatment in Parkinson’s disease
  Neurology and Clinical Neuroscience, 2014, 2(5), 149-155.

Petra Pohl, Nil Dizdar and Eva Hallert
  The Ronnie Gardiner Rhythm and Music Method – a feasibility study in Parkinson’s disease
  Disability and Rehabilitation, 2013, 35(26), 2197-2204.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Nil Dizdar, Peter Zsigmond, Anita Kullman and Dzeneta Nezirevic
  Letter: Untitled
  Journal of Neuroscience Methods, 2013, 212(2), 363-363.

Lasse Pihlstrøm, Gunnar Axelsson, Kari Anne Bjørnarå, Nil Dizdar, Camilla Fardell, Lars Forsgren, Björn Holmberg, Jan Petter Larsen, Jan Linder, Hans Nissbrandt, Ole-Bjørn Tysnes, Eilert Öhman, Espen Dietrichs and Mathias Toft
  Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease
  Neurobiology of Aging, 2013, 34(6), 1708.e7-1708.e13.
 Web of Science® Times Cited: 22

Caroline Ran, Thomas Willows, Olof Sydow, Anders Johansson, Peter Söderkvist, Nil Dizdar, Ahmad Ahmadi, Lars Olson and Carmine Belin
  The HLA-DRA variation rs3129882 is not associated with Parkinsons disease in Sweden
  Parkinsonism & Related Disorders, 2013, 19(7), 701-702.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Peter Zsigmond, Dzeneta Nezirevic Dernroth, Anita Kullman, Lars-Erik Augustinsson and Nil Dizdar
  Stereptactic microdialysis of the basal ganglia in Parkinson's disease
  Journal of Neuroscience Methods, 2012, 207(1), 17-22.
 Web of Science® Times Cited: 10

S. E. Pålhagen, Nil Dizdar, T. Hauge, B. Holmberg, R. Jansson, J. Linder, D. Nyholm, O. Sydow, M. Wainwright, H. Widner and A. Johansson
  Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease
  Acta Neurologica Scandinavica, 2012, 126(6), e29-e33.
 Web of Science® Times Cited: 19

Andrea Carmine Belin, Caroline Ran, Anna Anvret, Silvia Paddock, Marie Westerlund, Anna Håkansson, Hans Nissbrandt, Peter Söderkvist, Nil Dizdar, Ahmad Ahmadi, Maria Anvret, Thomas Willows, Olof Sydow and Dagmar Galter
  Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease
  Neuroscience Letters, 2012, 522(1), 30-5.
 Web of Science® Times Cited: 9

Elin Diczfalusy, Peter Zsigmond, Nil Dizdar, Anita Kullman, Dan Loyd and Karin Wårdell
  A model for simulation and patient-specific visualization of the tissue volume of influence during brain microdialysis
  Medical and Biological Engineering and Computing, 2011, 49(12), 1459-1469.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Istvan Gati, Olof Danielsson, T. Betmark, Jan Ernerudh, Karin Öllinger and Nil Dizdar
  Culturing of diagnostic muscle biopsies as spheroid-like structures: a pilot study of morphology and viability
  Neurological Research, 2010, 32(6), 650-655.
 Web of Science® Times Cited: 1

Maria Nord, Peter Zsigmond, Anita Kullman, Kerstin Årstrand and Nil Dizdar
  The Effect of Peripheral Enzyme Inhibitors on Levodopa Concentrations in Blood and CSF
  Movement Disorders, 2010, 25(3), 363-367.
 Web of Science® Times Cited: 4

Axel Petzold, Edward J Thompson, Geoffrey Keir, Niall Quinn, Bjorn Holmberg, Nil Dizdar-Segrell, Gregor K Wenning, Olivier Rascol, Eduardo Tolosa and Lars Rosengren
  Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy
  JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279(1-2), 76-79.
 Web of Science® Times Cited: 5

Dag Nyholm, R Constantinescu, B Holmberg, Nil Dizdar-Segrell and H Askmark
  Comparison of apomorphine and levodopa infusions in four patients with Parkinsons disease with symptom fluctuations
  Acta Neurologica Scandinavica, 2009, 119(5), 345-348.
 Web of Science® Times Cited: 20

Istvan Gati, Olof Danielsson, T Betmark, Jan Ernerudh, Karin Öllinger and Nil Dizdar-Segrell
  Effects of inhibitors of the arachidonic acid cascade on primary muscle culture from a Duchenne muscular dystrophy patient
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007, 77(3-4), 217-223.
 Web of Science® Times Cited: 7

B Holmberg, J O Johansson, W Poewe, G Wenning, N P Quinn, C Mathias, E Tolosa, A Cardozo, Nil Dizdar-Segrell, O Rascol and T Slaoui
  Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study
  Movement Disorders, 2007, 22(8), 1138-1144.
 Web of Science® Times Cited: 29

D Nyholm, AIM Nilsson Remahl, Nil Dizdar-Segrell, R Constantinescu, B Holmberg, R Jansson, SM Aquilonius and H Askmark
  Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
  Neurology, 2005, 64(2), 216-223.
 Web of Science® Times Cited: 236

Robert Kronstrand, Johan Ahlner, Nil Dizdar and Göran Larsson
  Quantitative Analysis of Desmethylselegiline, Methamphetamine, and Amphetamine in Hair and Plasma from Parkinson Patients on Long-Term Selegiline Medicatio
  Journal of Analytical Toxicology, 2003, 27(3), 135-141.
 Web of Science® Times Cited: 21

Nil Dizdar, Kerstin Årstrand and Bertil Kågedal
  Analysis of L-dopa in human serum
  BioTechniques, 2002, 33(5), 1000-1002.
 Web of Science® Times Cited: 1

Nil Dizdar (Segrell), Anita Kullman and Bertil Kågedal
  Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice
  Cancer chemotherapy and pharmacology, 2000, 45(3), 192-198.
 Web of Science® Times Cited: 5

Nil Dizdar (Segrell), Ann-Kathrine Granerus, Ulf Hannestad, Anita Kullman, Å. Ljungdahl, Jan-Edvin Olsson and Bertil Kågedal
  L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma
  Acta neurologica Scandinavica, 1999, 100(4), 231-237.

Nil Dizdar (Segrell), Anita Kullman, Björn Norlander, Jan-Edvin Olsson and Bertil Kågedal
  Human pharmacokinetics of L-3,4-dihydroxyphenylalanine studied with microdialysis
  Clinical Chemistry, 1999, 45(10), 1813-1820.

Nil Dizdar (Segrell), Anita Kullman, Bertil Kågedal and Kerstin Årstrand
  Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants
  Melanoma research, 1997, 7(4), 322.-328.

Nil Dizdar (Segrell), Bertil Kågedal, Staffan Smeds and Kerstin Årstrand
  A high-sensitivity fluorometric high-performance liquid chromatographic method for determination of glutathione and other thiols in cultured melanoma cells, microdialysis samples from melanoma tissue, and blood plasma.
  Melanoma Research, 1991, 1(1), 33-42.

Conference Articles

Anette Davidsson, Charalampos Georgiopoulos, Nil Dizdar-Segrell, Göran Granerus and Helene Zachrisson
  Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian snydromes using DaTSCAN SPECT
  Annaul Congress of the European Assocation of Nuclerar Medicine, Gothenburg, Sweden, October 18-22, 2014, 2014.


Elin Diczfalusy, Nil Dizdar, Peter Zsigmond, Anita Kullman, Dan Loyd and Karin Wårdell
  Simulations and visualizations for interpretation of brain microdialysis data during deep brain stimulation
  IEEE Engineering in Medicine and Biology Society (EMBC), 2012, 2012.


 Web of Science® Times Cited: 2

Charalampos Georgiopoulos, Anette Davidsson, Göran Granerus, Nil Dizdar and Helene Zachrisson
  DaTSCAN SPECT EVALUATION OF PATIENTS WITH MOVEMENT DISORDERS
  EUROPEAN JOURNAL OF NEUROLOGY, 2011.


Karin Wårdell, Marwan Hariz, Nil Dizdar-Segrell, Jan Hillman and Stefan Andersson-Engels
  Neuro-engineering for navigation, Intervention and Implementation in Neurosurgery
  Medicinteknikdagarna 2008,2008, 2008.


Ph.D. Theses

Peter Zsigmond
  Biochemical and pharmacokinetic studies in vivo in Parkinson’s disease
  2013.


  Fulltext PDF

Nil Dizdar (Segrell)
  Microdialysis as a Tool in Studies of L-Dopa and Metabolites in Malignant Melanoma and Parkinson’s Disease
  1999.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.

 



Responsible for this page: Peter Berkesand
Last updated: 2017-02-21